Novartis Seeks 'Amicable' Resolution Of German Probiotics Dispute
Executive Summary
Novartis is in discussion via its Hexal subsidiary with Germany's Association for Social Competition (VSW) over whether it must withdraw its Biosan range of probiotic supplements currently on the German market following a recent Higher Regional Court ruling.